| Mark Kenneth Magnus, DPM | |
|
1455 E Golf Rd Ste 110, Des Plaines, IL 60016-1253 | |
| (847) 390-7666 | |
| (847) 390-9345 |
| Full Name | Mark Kenneth Magnus |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 8 Years |
| Location | 1455 E Golf Rd Ste 110, Des Plaines, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710340724 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthdrive Podiatry Group Pc | 3375446958 | 99 |
News Archive
Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.
Patients with chronic prostatitis associated with chronic pelvic pain have substantial health care costs and have reduced quality of life, according to an article in the June 14 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
President Donald Trump announced last month that the GOP will become "the party of health care," and news reports suggest he intends to make it a top issue in his reelection campaign.
Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.
› Verified 3 days ago
| Provider Name | Gundersen Clinic Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851343115 PECOS PAC ID: 9638082779 Enrollment ID: O20031106000139 |
News Archive
Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.
Patients with chronic prostatitis associated with chronic pelvic pain have substantial health care costs and have reduced quality of life, according to an article in the June 14 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
President Donald Trump announced last month that the GOP will become "the party of health care," and news reports suggest he intends to make it a top issue in his reelection campaign.
Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.
› Verified 3 days ago
| Provider Name | Healthdrive Podiatry Group Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679504427 PECOS PAC ID: 3375446958 Enrollment ID: O20040928000155 |
News Archive
Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.
Patients with chronic prostatitis associated with chronic pelvic pain have substantial health care costs and have reduced quality of life, according to an article in the June 14 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
President Donald Trump announced last month that the GOP will become "the party of health care," and news reports suggest he intends to make it a top issue in his reelection campaign.
Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.
› Verified 3 days ago
| Provider Name | Family Foot And Ankle Clinic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659439321 PECOS PAC ID: 3072514876 Enrollment ID: O20070122000484 |
News Archive
Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.
Patients with chronic prostatitis associated with chronic pelvic pain have substantial health care costs and have reduced quality of life, according to an article in the June 14 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
President Donald Trump announced last month that the GOP will become "the party of health care," and news reports suggest he intends to make it a top issue in his reelection campaign.
Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.
› Verified 3 days ago
| Provider Name | Gundersen Lutheran Medical Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376593442 PECOS PAC ID: 2163331414 Enrollment ID: O20130619000254 |
News Archive
Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.
Patients with chronic prostatitis associated with chronic pelvic pain have substantial health care costs and have reduced quality of life, according to an article in the June 14 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
President Donald Trump announced last month that the GOP will become "the party of health care," and news reports suggest he intends to make it a top issue in his reelection campaign.
Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Kenneth Magnus, DPM Po Box 4340, Des Plaines, IL 60016-0014 Ph: (847) 390-7666 | Mark Kenneth Magnus, DPM 1455 E Golf Rd Ste 110, Des Plaines, IL 60016-1253 Ph: (847) 390-7666 |
News Archive
Dyax Corp. today announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication for KALBITOR (ecallantide), a peptide inhibitor of plasma kallikrein used in the treatment of acute hereditary angioedema (HAE) attacks, to include patients 12 years of age and older.
Patients with chronic prostatitis associated with chronic pelvic pain have substantial health care costs and have reduced quality of life, according to an article in the June 14 issue of the Archives of Internal Medicine, one of the JAMA/Archives journals.
President Donald Trump announced last month that the GOP will become "the party of health care," and news reports suggest he intends to make it a top issue in his reelection campaign.
Scientists at the Walter Reed Army Institute for Research have recently demonstrated that cathepsin B, a well-studied protein important to brain development and function, can be used as biomarker, or indicator of severity, for traumatic brain injury.
› Verified 3 days ago
Lowell Scott Weil Sr., DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1455 E Golf Rd, Suite 110, Des Plaines, IL 60016 Phone: 847-390-7666 Fax: 847-390-9345 | |
Podiatry Associates Ltd Podiatrist Medicare: Medicare Enrolled Practice Location: 770 Lee Street, Suite 101, Des Plaines, IL 60016 Phone: 847-298-5252 Fax: 847-298-0891 | |
Dr. James H. Lawton, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 1455 E Golf Rd, 110, Des Plaines, IL 60016 Phone: 847-390-7666 Fax: 847-390-9345 | |
Dr. Donna Jean Defronzo, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1455 E Golf Rd, Suite 110, Des Plaines, IL 60016 Phone: 847-390-7666 Fax: 847-390-9345 | |
Soyoung Kwon Dpm Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9820 Milwaukee Ave, C-d, Des Plaines, IL 60016 Phone: 847-213-9003 | |
Dr. Louis Anthony Sorto Jr., DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 770 Lee Street, Suite 101, Des Plaines, IL 60016 Phone: 847-298-5252 Fax: 847-298-0891 | |
Il Foot & Ankle Clinic Medical Corp Podiatrist Medicare: Medicare Enrolled Practice Location: 1400 E Golf Rd Ste 201, Des Plaines, IL 60016 Phone: 847-298-3338 Fax: 847-298-3334 |